Table 4 Comparison of pre- and post-treatment liver and kidney function indices.

From: Safety and effectiveness of dual therapy for Helicobacter pylori infection and the effect on the glycated hemoglobin level in type 2 diabetes

Variable

Pre-treatment (n = 37)

Post-treatment (n = 37)

p-value

Total bilirubin (μmol/L)

9.90 (6.90, 15.30)

12.10 (9.70, 14.60)

0.052

ALT (U/L)

19.10 (14.00, 23.80)

20.30 (16.00, 27.50)

0.245

AST (U/L)

19.00 (14.40, 24.00)

20.40 (17.00, 26.80)

0.478

Creatinine (μmol/L)

73.14 ± 13.80

74.02 ± 17.02

0.183

  1. AST, aspartate transaminase; ALT, Alanine aminotransferase.
Back to article page